Press releases 18 May 2022 Consortium formed to discover antivirals for COVID-19 receives NIH funding to develop globally accessible treatments for pandemics
In the media 16 May 2022 “Faire des produits de santé un bien commun mondial” interview avec Jean-Francois Alesandrini RFI Priorité Santé
In the media 5 May 2022 Enfin des médicaments contre les maladies négligées ! Alternatives Economiques
Press Releases Translations 29 Apr 2022 Kerjasama antara Kementerian Kesihatan Malaysia dengan Drugs for Neglected Diseases initiative bagi memimpin usaha memerangi wabak denggi
Press Releases Translations 29 Apr 2022 กระทรวงสาธารณสุข มาเลเซีย และ Drugs for Neglected Diseases initiative ผนึกกำลังเพื่อสู้กับโรคไข้เลือดออก
Press releases 29 Apr 2022 Ministry of Health, Malaysia and Drugs for Neglected Diseases initiative combine forces to lead the battle against dengue
In the media 26 Apr 2022 Rollout of new effective COVID pill mirrors the “injustice of vaccine apartheid” in poor countries Salon
In the media 25 Apr 2022 After a COVID expert struggled to obtain new treatments for his parents, he tweeted a road map The New Yorker
Scientific articles 14 Apr 2022 Understanding individual motivations among members of online communities Les Cahiers du Numérique
Scientific articles 15 Mar 2022 Development and introduction of fexinidazole into the Global Human African Trypanosomiasis Program The American Journal of Tropical Medicine and Hygiene
Scientific articles 14 Mar 2022 The pandemic response box ─ accelerating drug discovery efforts after disease outbreaks ACS Infectious Diseases
Scientific articles 10 Mar 2022 Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside PLOS Neglected Tropical Diseases
Scientific articles 7 Mar 2022 A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World PLOS Neglected Tropical Diseases
Scientific articles 3 Mar 2022 Open Synthesis Network research in an undergraduate laboratory: Development of benzoxazole amide derivatives against leishmania parasite Journal of Chemical Education
Scientific articles 15 Feb 2022 CACHE (Critical Assessment of Computational Hit-finding Experiments): A public–private partnership benchmarking initiative to enable the development of computational methods for hit-finding Nature Reviews Chemistry
Scientific articles 15 Feb 2022 The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern Nature Communications
Scientific articles 11 Feb 2022 AmBisome monotherapy and combination AmBisome – miltefosine therapy for the treatment of visceral leishmaniasis in patients co-infected with HIV in India: A randomised open label, parallel arm, phase III trial Clinical Infectious Diseases
Scientific articles 1 Jan 2022 The silent and dangerous inequity around access to COVID-19 testing: A call to action EClinicalMedicine
Scientific articles 24 Dec 2021 Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study BMJ Open
Scientific articles 21 Dec 2021 Interruption of mother-to-child transmission and detection and treatment of children of infected mothers as a contribution to eradicate Chagas disease in Europe Real Academia Nacional de Medicina
Scientific articles 3 Dec 2021 Target 2035 – update on the quest for a probe for every protein RSC Medicinal Chemistry
Scientific articles 2 Dec 2021 Pharmacokinetics and safety of the abacavir/ lamivudine/ lopinavir/ ritonavir fixed-dose granule formulation (4-in-1) in neonates Journal of Acquired Immune Deficiency Syndromes
Scientific articles 18 Nov 2021 Geographic variations in test reactivity for the serological diagnosis of Trypanosoma cruzi infection Journal of Clinical Microbiology
